Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
QUININE
(2005)
Small molecule
Unknown
Unknown
Approved
Malaria
QUININE
×
Maximum Phase:
4
First Approval:
2005
UNII:
A7V27PHC7A
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O2
Molecular Weight:
324.42
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SORAFENIB
(2005)
Small molecule
Unknown
ORAL
Approved
Carcinoma, Renal Cell; Neoplasms
SORAFENIB
×
Maximum Phase:
4
First Approval:
2005
UNII:
9ZOQ3TZI87
Molecule Type:
Small molecule
Molecular Formula:
C21H16ClF3N4O3
Molecular Weight:
464.83
AlogP:
5.55
PSA:
92.35
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CLOBAZAM
(2005)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
ORAL
Approved
Anxiety; Lennox Gastaut Syndrome; Seizures
CLOBAZAM
×
Maximum Phase:
4
First Approval:
2005
UNII:
2MRO291B4U
Molecule Type:
Small molecule
Molecular Formula:
C16H13ClN2O2
Molecular Weight:
300.75
AlogP:
3.37
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESOMEPRAZOLE SODIUM
(2005)
Small molecule
Potassium-transporting ATPase inhibitor
INTRAVENOUS
Approved
Duodenal Ulcer; Gastroesophageal Reflux
ESOMEPRAZOLE SODIUM
×
Maximum Phase:
4
First Approval:
2005
UNII:
L2C9GWQ43H
Molecule Type:
Small molecule
Molecular Formula:
C17H18N3NaO3S
Molecular Weight:
367.41
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LEVALBUTEROL TARTRATE
(2005)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Unknown
LEVALBUTEROL TARTRATE
×
Maximum Phase:
4
First Approval:
2005
UNII:
ADS4I3E22M
Molecule Type:
Small molecule
Molecular Formula:
C30H48N2O12
Molecular Weight:
628.72
AlogP:
1.31
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
4.0
Source:
ENTECAVIR
(2005)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
ORAL
Approved
Hepatitis B; Hepatitis B, Chronic; Liver Diseases; Virus Diseases
ENTECAVIR
×
Maximum Phase:
4
First Approval:
2005
UNII:
5968Y6H45M
Molecule Type:
Small molecule
Molecular Formula:
C12H15N5O3
Molecular Weight:
277.28
AlogP:
-0.83
PSA:
130.05
HBD:
4.0
HBA:
#RotB:
2.0
Source:
CONIVAPTAN
(2005)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
CONIVAPTAN
×
Maximum Phase:
4
First Approval:
2005
UNII:
0NJ98Y462X
Molecule Type:
Small molecule
Molecular Formula:
C32H26N4O2
Molecular Weight:
498.59
AlogP:
6.51
PSA:
78.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CONIVAPTAN HYDROCHLORIDE
(2005)
Small molecule
Vasopressin V1a receptor antagonist
INJECTION; INTRAVENOUS
Approved
Heart Failure
CONIVAPTAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2005
UNII:
75L57R6X36
Molecule Type:
Small molecule
Molecular Formula:
C32H27ClN4O2
Molecular Weight:
535.05
AlogP:
6.51
PSA:
78.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LENALIDOMIDE
(2005)
Small molecule
CRL4(CRBN) E3 ubiquitin ligase inhibitor
ORAL
Approved
Anemia; Immune System Diseases; Lymphoma, Mantle-Cell; Multiple Myeloma; Myelodysplastic Syndromes
LENALIDOMIDE
×
Maximum Phase:
4
First Approval:
2005
UNII:
F0P408N6V4
Molecule Type:
Small molecule
Molecular Formula:
C13H13N3O3
Molecular Weight:
259.26
AlogP:
0.03
PSA:
92.5
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DIPHENHYDRAMINE CITRATE
(2005)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Burns; Common Cold; Cough; Dizziness; Insect Bites and Stings; Motion Sickness; Nasal Obstruction; Nausea; Postoperative Nausea and Vomiting; Pruritus; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Sleep Initiation and Maintenance Disorders; Sunburn; Vomiting
DIPHENHYDRAMINE CITRATE
×
Maximum Phase:
4
First Approval:
2005
UNII:
4OD433S209
Molecule Type:
Small molecule
Molecular Formula:
C23H29NO8
Molecular Weight:
447.48
AlogP:
3.35
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MICAFUNGIN
(2005)
Small molecule
Unknown
Unknown
Approved
Unknown
MICAFUNGIN
×
Maximum Phase:
4
First Approval:
2005
UNII:
R10H71BSWG
Molecule Type:
Small molecule
Molecular Formula:
C56H71N9O23S
Molecular Weight:
1270.29
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TETRACAINE
(2005)
Small molecule
Sodium channel alpha subunit blocker
Unknown
Approved
Hemorrhoids; Pain; Pruritus
TETRACAINE
×
Maximum Phase:
4
First Approval:
2005
UNII:
0619F35CGV
Molecule Type:
Small molecule
Molecular Formula:
C15H24N2O2
Molecular Weight:
264.37
AlogP:
2.62
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
8.0
Source:
RAMELTEON
(2005)
Small molecule
Melatonin receptor agonist
ORAL
Approved
Sleep Initiation and Maintenance Disorders
RAMELTEON
×
Maximum Phase:
4
First Approval:
2005
UNII:
901AS54I69
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.57
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DEFERASIROX
(2005)
Small molecule
Iron chelating agent
ORAL
Approved
Myelodysplastic Syndromes
DEFERASIROX
×
Maximum Phase:
4
First Approval:
2005
UNII:
V8G4MOF2V9
Molecule Type:
Small molecule
Molecular Formula:
C21H15N3O4
Molecular Weight:
373.37
AlogP:
3.71
PSA:
108.47
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIPRANAVIR
(2005)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Hemorrhage; Virus Diseases
TIPRANAVIR
×
Maximum Phase:
4
First Approval:
2005
UNII:
ZZT404XD09
Molecule Type:
Small molecule
Molecular Formula:
C31H33F3N2O5S
Molecular Weight:
602.68
AlogP:
7.33
PSA:
105.59
HBD:
2.0
HBA:
#RotB:
11.0
Source:
NEPAFENAC
(2005)
Small molecule
Cyclooxygenase inhibitor
OPHTHALMIC
Approved
Cataract; Eye Diseases; Inflammation
NEPAFENAC
×
Maximum Phase:
4
First Approval:
2005
UNII:
0J9L7J6V8C
Molecule Type:
Small molecule
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.29
AlogP:
1.53
PSA:
86.18
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ZINC OXIDE
(2006)
Small molecule
Sunscreen/skin protectant
Unknown
Approved
Anemia; Anemia, Iron-Deficiency; Burns; Dermatitis; Diaper Rash; Exanthema; Fever; Hemorrhage; Hemorrhoids; Lymphedema; Neoplasms; Pruritus; Psoriasis; Skin Neoplasms; Sprains and Strains; Sunburn; Thrombophlebitis; Varicose Ulcer
ZINC OXIDE
×
Maximum Phase:
4
First Approval:
2006
UNII:
SOI2LOH54Z
Molecule Type:
Small molecule
Molecular Formula:
OZn
Molecular Weight:
81.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SITAXENTAN SODIUM
(2006)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
Unknown
Approved
Unknown
SITAXENTAN SODIUM
×
Maximum Phase:
4
First Approval:
2006
UNII:
6V9JH46E20
Molecule Type:
Small molecule
Molecular Formula:
C18H14ClN2NaO6S2
Molecular Weight:
476.9
AlogP:
3.96
PSA:
107.73
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARFORMOTEROL
(2006)
Small molecule
Unknown
Unknown
Approved
Unknown
ARFORMOTEROL
×
Maximum Phase:
4
First Approval:
2006
UNII:
F91H02EBWT
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O4
Molecular Weight:
344.41
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
CARVEDILOL PHOSPHATE
(2006)
Small molecule
Adrenergic receptor alpha-1 antagonist
ORAL
Approved
Hypertension; Myocardial Infarction; Ventricular Dysfunction, Left
CARVEDILOL PHOSPHATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
EQT531S367
Molecule Type:
Small molecule
Molecular Formula:
C24H29N2O8P
Molecular Weight:
504.48
AlogP:
3.74
PSA:
75.74
HBD:
3.0
HBA:
#RotB:
10.0
Source:
LUBIPROSTONE
(2006)
Small molecule
Chloride channel protein 2 opener
ORAL
Approved
Chronic Pain; Constipation; Irritable Bowel Syndrome
LUBIPROSTONE
×
Maximum Phase:
4
First Approval:
2006
UNII:
7662KG2R6K
Molecule Type:
Small molecule
Molecular Formula:
C20H32F2O5
Molecular Weight:
390.47
AlogP:
4.31
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
11.0
Source:
DECITABINE
(2006)
Small molecule
DNA (cytosine-5)-methyltransferase 1 inhibitor
INTRAVENOUS
Approved
Anemia; Anemia, Refractory, with Excess of Blasts; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms
DECITABINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
776B62CQ27
Molecule Type:
Small molecule
Molecular Formula:
C8H12N4O4
Molecular Weight:
228.21
AlogP:
-2.14
PSA:
123.49
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TELBIVUDINE
(2006)
Small molecule
DNA polymerase/reverse transcriptase inhibitor
Unknown
Approved
Hepatitis B, Chronic; Virus Diseases
TELBIVUDINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
2OC4HKD3SF
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O5
Molecular Weight:
242.23
AlogP:
-1.51
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
IBUPROFEN LYSINE
(2006)
Small molecule
Cyclooxygenase inhibitor
Unknown
Approved
Ductus Arteriosus, Patent
IBUPROFEN LYSINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
N01ORX9D6S
Molecule Type:
Small molecule
Molecular Formula:
C19H32N2O4
Molecular Weight:
352.48
AlogP:
3.07
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ANIDULAFUNGIN
(2006)
Small molecule
1,3-beta-glucan synthase inhibitor
INJECTION; INTRAVENOUS
Approved
Candidemia; Candidiasis; Peritonitis
ANIDULAFUNGIN
×
Maximum Phase:
4
First Approval:
2006
UNII:
9HLM53094I
Molecule Type:
Small molecule
Molecular Formula:
C58H73N7O17
Molecular Weight:
1140.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VARENICLINE
(2006)
Small molecule
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
ORAL
Approved
Tobacco Use Disorder
VARENICLINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
W6HS99O8ZO
Molecule Type:
Small molecule
Molecular Formula:
C13H13N3
Molecular Weight:
211.27
AlogP:
1.8
PSA:
37.81
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SUNITINIB
(2006)
Small molecule
Unknown
Unknown
Approved
Neoplasms
SUNITINIB
×
Maximum Phase:
4
First Approval:
2006
UNII:
V99T50803M
Molecule Type:
Small molecule
Molecular Formula:
C22H27FN4O2
Molecular Weight:
398.48
AlogP:
3.33
PSA:
77.23
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TETRACYCLINE
(2006)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Approved
Bacterial Infections; Eye Infections; Infections
TETRACYCLINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
F8VB5M810T
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O8
Molecular Weight:
444.44
AlogP:
-0.21
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
RANOLAZINE
(2006)
Small molecule
Sodium channel protein type IV alpha subunit blocker
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases
RANOLAZINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
A6IEZ5M406
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4
Molecular Weight:
427.55
AlogP:
2.31
PSA:
74.27
HBD:
2.0
HBA:
#RotB:
9.0
Source:
CICLESONIDE
(2006)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL
Approved
Asthma; Lung Diseases, Obstructive; Nasal Obstruction; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
CICLESONIDE
×
Maximum Phase:
4
First Approval:
2006
UNII:
S59502J185
Molecule Type:
Small molecule
Molecular Formula:
C32H44O7
Molecular Weight:
540.7
AlogP:
4.7
PSA:
99.13
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TITANIUM DIOXIDE
(2006)
Small molecule
Unknown
Unknown
Approved
Unknown
TITANIUM DIOXIDE
×
Maximum Phase:
4
First Approval:
2006
UNII:
15FIX9V2JP
Molecule Type:
Small molecule
Molecular Formula:
O2Ti
Molecular Weight:
79.86
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RASAGILINE MESYLATE
(2006)
Small molecule
Monoamine oxidase B inhibitor
ORAL
Approved
Parkinson Disease
RASAGILINE MESYLATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
LH8C2JI290
Molecule Type:
Small molecule
Molecular Formula:
C13H17NO3S
Molecular Weight:
267.35
AlogP:
1.9
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SUNITINIB MALATE
(2006)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Gastrointestinal Stromal Tumors; Neuroendocrine Tumors
SUNITINIB MALATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
LVX8N1UT73
Molecule Type:
Small molecule
Molecular Formula:
C26H33FN4O7
Molecular Weight:
532.57
AlogP:
3.33
PSA:
77.23
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DARUNAVIR
(2006)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Virus Diseases
DARUNAVIR
×
Maximum Phase:
4
First Approval:
2006
UNII:
YO603Y8113
Molecule Type:
Small molecule
Molecular Formula:
C27H37N3O7S
Molecular Weight:
547.67
AlogP:
2.38
PSA:
140.42
HBD:
3.0
HBA:
#RotB:
11.0
Source:
LACTIC ACID
(2006)
Small molecule
pH lowering agent
Unknown
Approved
Acid-Base Imbalance; Electrolytes
LACTIC ACID
×
Maximum Phase:
4
First Approval:
2006
UNII:
33X04XA5AT
Molecule Type:
Small molecule
Molecular Formula:
C3H6O3
Molecular Weight:
90.08
AlogP:
-0.55
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
1.0
Source:
POSACONAZOLE
(2006)
Small molecule
Cytochrome P450 51 inhibitor
INTRAVENOUS; ORAL
Approved
Aspergillosis; Candidiasis; Neutropenia
POSACONAZOLE
×
Maximum Phase:
4
First Approval:
2006
UNII:
6TK1G07BHZ
Molecule Type:
Small molecule
Molecular Formula:
C37H42F2N8O4
Molecular Weight:
700.79
AlogP:
4.57
PSA:
115.7
HBD:
1.0
HBA:
#RotB:
12.0
Source:
1
2
…
55
56
57
58
59
60
61
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA